Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jing Chen, Hongbo Wu, Xudong Tang & Lei Chen. (2022) 4-Phenylbutyrate protects against rifampin-induced liver injury via regulating MRP2 ubiquitination through inhibiting endoplasmic reticulum stress. Bioengineered 13:2, pages 2866-2877.
Read now
Read now
Articles from other publishers (3)
Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G. G. Sturkenboom, Jan-Willem C. Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W. Akkerman, Adrian Sanchez-Montalva & Cecile Magis-Escurra. (2022) Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial. Pharmaceutics 15:1, pages 9.
Crossref
Crossref
Wanqing Hou, Bernard Nsengimana, Chuyun Yan, Bjorn Nashan & Shuxin Han. (2022) Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury. Frontiers in Pharmacology 13.
Crossref
Crossref
Yu-Qing Guo, Yi-Jie Zhang, Yun-Zhi Pan, Mei-Ying Wu, Jia Liu & Wei Yang. (2022) Recent advances in research of modes of hepatocyte death in anti-tuberculosis drug-induced liver injury. World Chinese Journal of Digestology 30:18, pages 817-822.
Crossref
Crossref